Therapeutic antibodies for autoimmunity and inflammation - PubMed (original) (raw)

Review

doi: 10.1038/nri2761.

Affiliations

• PMID: 20414204
• DOI: 10.1038/nri2761

Review

Therapeutic antibodies for autoimmunity and inflammation

Andrew C Chan et al. Nat Rev Immunol. 2010 May.

Abstract

The development of therapeutic antibodies has evolved over the past decade into a mainstay of therapeutic options for patients with autoimmune and inflammatory diseases. Substantial advances in understanding the biology of human diseases have been made and tremendous benefit to patients has been gained with the first generation of therapeutic antibodies. The lessons learnt from these antibodies have provided the foundation for the discovery and development of future therapeutic antibodies. Here we review how key insights obtained from the development of therapeutic antibodies complemented by newer antibody engineering technologies are delivering a second generation of therapeutic antibodies with promise for greater clinical efficacy and safety.

PubMed Disclaimer

Similar articles

• A bispecific antibody that targets IL-6 receptor and IL-17A for the potential therapy of patients with autoimmune and inflammatory diseases.
  Lyman M, Lieuw V, Richardson R, Timmer A, Stewart C, Granger S, Woods R, Silacci M, Grabulovski D, Newman R. Lyman M, et al. J Biol Chem. 2018 Jun 15;293(24):9326-9334. doi: 10.1074/jbc.M117.818559. Epub 2018 Apr 20. J Biol Chem. 2018. PMID: 29678878 Free PMC article.
• Strategies and challenges for the next generation of therapeutic antibodies.
  Beck A, Wurch T, Bailly C, Corvaia N. Beck A, et al. Nat Rev Immunol. 2010 May;10(5):345-52. doi: 10.1038/nri2747. Nat Rev Immunol. 2010. PMID: 20414207 Review.
• Bispecific Antibodies for Autoimmune and Inflammatory Diseases: Clinical Progress to Date.
  Zhao Q. Zhao Q. BioDrugs. 2020 Apr;34(2):111-119. doi: 10.1007/s40259-019-00400-2. BioDrugs. 2020. PMID: 31916225 Review.
• The therapeutic potential of the targeted autoreactive B lymphocytes by rituximab in SLE.
  Wang C, Pan HF, Ye DQ. Wang C, et al. Autoimmun Rev. 2012 Mar;11(5):373. doi: 10.1016/j.autrev.2011.01.002. Epub 2011 Jan 9. Autoimmun Rev. 2012. PMID: 21224014 No abstract available.
• [Biological response modifiers in the treatment of immunoinflammatory diseases].
  Skov L, Bendtzen K. Skov L, et al. Ugeskr Laeger. 2008 Jun 9;170(24):2120-6. Ugeskr Laeger. 2008. PMID: 18565292 Review. Danish.

Cited by

• Prediction of anti-inflammatory peptides by a sequence-based stacking ensemble model named AIPStack.
  Deng H, Lou C, Wu Z, Li W, Liu G, Tang Y. Deng H, et al. iScience. 2022 Aug 17;25(9):104967. doi: 10.1016/j.isci.2022.104967. eCollection 2022 Sep 16. iScience. 2022. PMID: 36093066 Free PMC article.
• A Neutralizing Antibody Assay Based on a Reporter of Antibody-Dependent Cell-Mediated Cytotoxicity.
  Wu Y, Li JJ, Kim HJ, Liu X, Liu W, Akhgar A, Bowen MA, Spitz S, Jiang XR, Roskos LK, White WI. Wu Y, et al. AAPS J. 2015 Nov;17(6):1417-26. doi: 10.1208/s12248-015-9798-5. Epub 2015 Jul 24. AAPS J. 2015. PMID: 26205082 Free PMC article.
• Intact glycopeptide characterization using mass spectrometry.
  Cao L, Qu Y, Zhang Z, Wang Z, Prytkova I, Wu S. Cao L, et al. Expert Rev Proteomics. 2016 May;13(5):513-22. doi: 10.1586/14789450.2016.1172965. Expert Rev Proteomics. 2016. PMID: 27140194 Free PMC article. Review.
• Pulmonary monoclonal antibody delivery via a portable microfluidic nebulization platform.
  Cortez-Jugo C, Qi A, Rajapaksa A, Friend JR, Yeo LY. Cortez-Jugo C, et al. Biomicrofluidics. 2015 Apr 8;9(5):052603. doi: 10.1063/1.4917181. eCollection 2015 Sep. Biomicrofluidics. 2015. PMID: 25945147 Free PMC article.
• Preliminary Investigation and Therapeutic Efficacy Determination of a Novel Anti-IL-17A Antibody, Indikizumab.
  Patra AK, Nayak S, Moharana A, Ojha P, Das SK, Akhtar J, Giri B, Singh S. Patra AK, et al. Biologics. 2024 Sep 17;18:257-271. doi: 10.2147/BTT.S477752. eCollection 2024. Biologics. 2024. PMID: 39319321 Free PMC article.

References

1. 1. Arthritis Rheum. 2003 Feb;48(2):455-9 - PubMed
2. 1. Immunol Rev. 2008 Jun;223:20-38 - PubMed
3. 1. Nature. 1962 Apr 28;194:355-9 - PubMed
4. 1. Front Biosci. 2008 Jan 01;13:1117-29 - PubMed
5. 1. J Immunol. 1997 Feb 1;158(3):1438-45 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal